- €46.17bn
- €78.52bn
- €45.58bn
Judge criticizes proposed $7.25 billion Roundup settlement
US House passes farm bill after scrapping pesticide language opposed by MAHA
Syngenta sees strong growth in China as Q1 sales rise
Brief: Bayer AG - China's Center Of Drug Evaluation Accepts Marketing Authorization Application For Asundexian
Secured Fixed Income - PCA Dealing
Bayer shares slide after U.S. Supreme Court split over Bayer's fight against Roundup lawsuits
Bayer down after 'mixed reception' at U.S Supreme Court
With Bayer at US Supreme Court, MAHA rallies against pesticides
Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits?
US Supreme Court hears Bayer's fight against Roundup lawsuits (updated)
US Supreme Court hears Bayer's fight against Roundup lawsuits
Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits?
As Roundup maker goes to Supreme Court, Americans worry about pesticides, Reuters/Ipsos poll shows (updated)
Bayer says it has not been asked by US to negotiate drug prices
Brief: Bayer CEO: We Still Do Not Intend To Resort To A Capital Increase
As Roundup maker goes to Supreme Court, Americans worry about pesticides, Reuters/Ipsos poll shows
Brief: Bayer: Askbio's Viralgen To Supply Drug Product For Regenerate-PD Investigational Gene Therapy Phase Ii Trial
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims (updated)
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims (updated)